BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 35982454)

  • 1. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
    Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
    Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection.
    Torices S; Cabrera R; Stangis M; Naranjo O; Fattakhov N; Teglas T; Adesse D; Toborek M
    J Neuroinflammation; 2021 Jul; 18(1):167. PubMed ID: 34325716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
    Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
    J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
    Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
    Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
    Alam SB; Willows S; Kulka M; Sandhu JK
    Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
    Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
    Front Immunol; 2021; 12():697329. PubMed ID: 34386007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of SARS-CoV-2 with the Blood-Brain Barrier.
    Erickson MA; Rhea EM; Knopp RC; Banks WA
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations.
    Yepes M
    Curr Drug Targets; 2022; 23(17):1620-1638. PubMed ID: 36121081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
    Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
    Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of SARS-CoV-2 infection.
    Meinhardt J; Streit S; Dittmayer C; Manitius RV; Radbruch H; Heppner FL
    Nat Rev Neurosci; 2024 Jan; 25(1):30-42. PubMed ID: 38049610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
    Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
    Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SARS-CoV-2-related Receptors in Cells of the Neurovascular Unit: Implications for HIV-1 Infection.
    Torices S; Cabrera R; Stangis M; Naranjo O; Adesse D; Toborek M
    Res Sq; 2021 Feb; ():. PubMed ID: 33655239
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2: is there neuroinvasion?
    McQuaid C; Brady M; Deane R
    Fluids Barriers CNS; 2021 Jul; 18(1):32. PubMed ID: 34261487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
    Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
    J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
    Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
    Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible routes of SARS-CoV-2 invasion in brain: In context of neurological symptoms in COVID-19 patients.
    Kumar A; Pareek V; Prasoon P; Faiq MA; Kumar P; Kumari C; Narayan RK
    J Neurosci Res; 2020 Dec; 98(12):2376-2383. PubMed ID: 32869376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.